Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


DART takes aim at community editing

An Author Correction to this article was published on 06 January 2022

This article has been updated

Advances in CRISPR–Cas tools coupled with innovative screening and bioinformatic pipelines make it possible to conduct strain-specific and site-specific genome editing within a microbial community without the need for prior culturing or engineering.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Conceptual overview of the ET-seq and VcDART toolkit for bacterial genomic editing.

Change history


  1. Rubin, B. E. et al. Nat Microbiol. (2021).

  2. Ronda, C., Chen, S. P., Cabral, V., Yaung, S. J. & Wang, H. H. Nat. Methods 16, 167–170 (2019).

    Article  CAS  Google Scholar 

  3. Vo, P. L. H. et al. Nat. Biotechnol. 39, 480–489 (2021).

    Article  CAS  Google Scholar 

  4. Bayer, C. N., Rennig, M., Ehrmann, A. K. & Nørholm, M. H. H. Nat. Commun. 12, 5876 (2021).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Suzanne Devkota.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ha, C.W.Y., Devkota, S. DART takes aim at community editing. Nat Microbiol 7, 8–9 (2022).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research